Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 18.76M
March 31, 2026 18.76M
December 31, 2025 18.76M
September 30, 2025 18.72M
June 30, 2025 18.72M
March 31, 2025 18.70M
December 31, 2024 18.70M
September 30, 2024 18.76M
June 30, 2024 18.76M
March 31, 2024 18.76M
December 31, 2023 18.76M
September 30, 2023 18.76M
June 30, 2023 18.76M
March 31, 2023 18.76M
December 31, 2022 18.76M
September 30, 2022 18.76M
June 30, 2022 18.76M
March 31, 2022 18.76M
December 31, 2021 18.76M
September 30, 2021 18.76M
June 30, 2021 18.76M
March 31, 2021 18.76M
December 31, 2020 18.76M
September 30, 2020 18.76M
June 30, 2020 18.76M
Date Value
March 31, 2020 17.76M
December 31, 2019 17.76M
September 30, 2019 17.76M
June 30, 2019 17.76M
March 31, 2019 17.76M
December 31, 2018 17.76M
September 30, 2018 17.76M
June 30, 2018 17.76M
March 31, 2018 17.76M
December 31, 2017 17.76M
September 30, 2017 17.76M
June 30, 2017 17.76M
March 31, 2017 17.76M
December 31, 2016 17.76M
September 30, 2016 17.76M
June 30, 2016 17.76M
March 31, 2016 17.76M
December 31, 2015 17.76M
September 30, 2015 17.76M
June 30, 2015 17.76M
March 31, 2015 17.26M
December 31, 2014 17.26M
September 30, 2014 16.81M
June 30, 2014 16.81M
March 31, 2014 16.81M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Ottobock SE & Co. KGaA 319.95M
Abbott Laboratories 1.730B
AngioDynamics, Inc. 41.70M
Alphatec Holdings, Inc. 152.68M
AtriCure, Inc. 50.86M